Key result
mHealth app evaluated for systolic blood pressure reduction in planned cluster randomized trial.
Why the study?
Existing mHealth applications in India for hypertension lack customization for user needs, limiting their usability for remote monitoring and self-management.
Does a customized mHealth application improve health status, knowledge, and self-care in individuals with hypertension?
RCT (n=236)
Open-label
Block randomization at the cluster level
Yes
Does a customized mHealth application improve health status, knowledge, and self-care in individuals with hypertension?
This study protocol outlines a cluster randomized trial to evaluate a customized mHealth application for hypertension self-management in rural India.
Protocol for tailored mHealth app in rural India; leaves open whether customised self-management improves BP control over standard care.
Background Hypertension is a significant risk factor for cardiovascular disease, contributing to global mortality and disability. Approximately 30% of Indian adults are diagnosed with hypertension. Evidence supports that self-monitoring and blood pressure self-management can lower systolic BP by an average of 3.2 mmHg. mHealth applications facilitate remote monitoring and self-management, yet existing applications in India lack customisation for user needs, limiting their usability. This study aims to develop and evaluate a novel, user-friendly mHealth application tailored to hypertensive individuals. Methods This study follows an Agile development design, an iterative software development approach that allows continuous feedback and refinement. The research will be conducted in three phases over an anticipated duration of 27 months. Phase 1 (6 months) will involve in-depth interviews and focus group discussions to identify essential features for a customised Android-based mHealth application. Phase 2 (9 months) will involve developing the application using Android Studio following Agile principles. Phase 3 (12 months) will be a community-based cluster randomised trial conducted in 12 villages to evaluate the application’s effectiveness. Villages will be randomised into intervention and control groups. Each group will include 118 participants. The intervention group will use the mHealth application, while the control group will follow the standard hypertension management regimen. Villages and participants will be selected based on specific criteria, including population size, availability of healthcare facilities, and smartphone accessibility among hypertensive patients. Results In the proposed study, if the intervention is helpful, hypertension patients in the community can be encouraged to use the mHealth application. If found effective, this application is anticipated to improve hypertensive patients’ health status, knowledge, and self-care approach. Registration: Clinical Trials Registry - India ( CTRI/2022/03/041544 ).
No takes yet. Share an insight, caveat, or question.
Salins et al. (2025) conducted an RCT in Primary hypertension (n=236). Customized mHealth application vs. Standard care was evaluated on Mean systolic blood pressure reduction. A customized mHealth application for remote monitoring and self-management of hypertension will be evaluated for its effect on systolic blood pressure in a planned cluster randomized trial of 236 adults in India.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: